RegeneRx PipelineRegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company focused on tissue protection, repair and regeneration with an extensive portfolio of product candidates for first-in-class therapeutic peptides.
|
Latest News:
September 2, 2010
RegeneRx Appoints R. Don Elsey to Board of Directors
August 2, 2010
British Researchers Report that Tβ4 is Essential to Heart Development
July 19, 2010
Researchers Report in Neuroscience that Tβ4 Improves Neurological Function after Stroke
July 8, 2010
RegeneRx Awarded Australian Patent for New Tβ4 Applications